November 12, 2026 at 09:09 PM UTC

8-K - ADARx Pharmaceuticals, Inc. (0001802369) (Filer)

Filed: 2026-11-12 AccNo: 0001193125-26-458321 Size: 17 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Official source: U.S. Securities and Exchange Commission

Official source published: November 12, 2026 at 09:05 PM UTC

Open official source